MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RGBBX | 42.48 | 0.01 | +0.02% |
| American Funds Global Balanced R-2 | |||
| SCRLX | 89.90 | N/A | N/A |
| Touchstone Large Cap Focused Instl | |||
| DLDRX | 65.16 | N/A | N/A |
| BNY Mellon Natural Resources I | |||
| JFACX | 36.46 | N/A | N/A |
| JHancock Fundamental All Cap Core R2 | |||
| SBASX | 14.25 | N/A | N/A |
| Segall Bryant &Hamill Small Cap Cre Ins | |||
MPLT saw its Momentum Indicator move above the 0 level on August 25, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator turned positive. In 18 of the 20 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MPLT's RSI Oscillator exited the oversold zone, 2 of 3 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for MPLT just turned positive on August 17, 2026. Looking at past instances where MPLT's MACD turned positive, the stock continued to rise in 4 of 5 cases over the following month. The odds of a continued upward trend are 80%.
Following a +6.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where MPLT advanced for three days, in 38 of 44 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 6 of 7 cases where MPLT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MPLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
MPLT broke above its upper Bollinger Band on August 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.731) is normal, around the industry mean (19.994). P/E Ratio (0.000) is within average values for comparable stocks, (27.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.527). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (427.627).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. MPLT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MPLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.